×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $8.12 B
Last 13-F Filed: Q3 2025
Concentration in top 10: 63.91%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
NUVLNUVALENT INC-A1.32%1,246,456$107,793,5151,246,456New$86.4813F
BCRXBioCryst Pharmaceuticals, Inc.1.25%15,302,186$103,442,77715,302,186New13G
BLTEBELITE BIO INC - ADR0.80%875,000$64,750,000875,000New$7413F
LXEOLexeo Therapeutics, Inc.0.57%5,000,000$46,100,0005,000,000New13G
EVMNEvommune, Inc.0.53%2,674,425$42,790,8002,674,425NewForm 4
VORVor Biopharma Inc.0.48%1,401,226$39,388,4631,401,226NewForm 4
LBRXLB PHARMACEUTICALS INC0.34%1,776,958$28,058,1671,776,958New$15.7913F
ASMBASSEMBLY BIOSCIENCES INC0.32%1,020,410$26,122,4961,020,410New$25.613F
CTNMCONTINEUM THERAPEUTICS INC-A0.31%2,122,000$24,933,5002,122,000New$11.7513F
BNTCBenitec Biopharma Inc.0.29%1,850,000$23,661,5001,850,000New13G
CCCCC4 Therapeutics, Inc.0.28%9,441,256$22,375,7779,441,256New13G
RANIRANI THERAPEUTICS HOLDINGS, INC.0.26%9,882,477$20,654,3779,882,477New13G
IVVDINVIVYD INC0.23%17,119,096$18,831,00617,119,096New$1.113F
PALIPALISADE BIO, INC.0.21%9,935,761$16,890,7949,935,761New13G
PRMEPRIME MEDICINE INC0.20%3,000,000$16,620,0003,000,000New$5.5413F
QUREUNIQURE NV0.14%200,000$11,674,000200,000New$58.3713F
SABSSAB BIOTHERAPEUTICS INC0.11%4,401,500$8,847,0154,401,500New$2.0113F
INSPINSPIRE MEDICAL SYSTEMS INC0.10%114,901$8,525,654114,901New$74.213F
EVHEVOLENT HEALTH INC - A0.06%579,052$4,898,780579,052New$8.4613F
GKOSGLAUKOS CORP0.05%54,180$4,418,37954,180New$81.5513F
DSGNDESIGN THERAPEUTICS INC0.04%475,699$3,582,013475,699New$7.5313F
EXASEXACT SCIENCES CORP0.04%54,939$3,005,71354,939New$54.7113F
PGNYPROGYNY INC0.03%96,628$2,079,43596,628New$21.5213F